Get owned

More than 40 countries have reached deals with the makers of the vaccine, many of which have little ability to access the in-demand shots made by Western companies that are powering vaccination drives in the US and Europe.

The Russian Direct Investment Fund, the body that backed the vaccine and handles its marketing, listed the nations in a press release Wednesday.

They are:

Europe: Russia, Belarus, Serbia, Slovakia, Hungary, Armenia, Montenegro, San Marino, Moldova.

Asia: Turkmenistan, Pakistan, Kazakhstan, Uzbekistan, Syria, Kyrgyzstan, Myanmar, Syria, Mongolia, Sri Lanka.

Americas: Argentina, Bolivia, Venezuela, Paraguay, Mexico, Nicaragua, Guyana, Saint Vincent and the Grenadines, Honduras, Guatemala.

Africa and Middle East: Algeria, Angola, the Republic of the Congo, Djibouti, Republic of Guinea, Tunisia, United Arab Emirates, Iran, Bahrain, Lebanon, Gabon, Egypt, Ghana.

The vaccine is also approved by the Palestinian Authority and by an entity of Bosnia and Herzegovina called the Srpska Republic, the press release said.

  • AlexisOhanian [he/him]
    hexagon
    ·
    4 years ago

    Also the 66% efficacy rate at avoiding all symptoms is a lot less important than its efficacy in saving peoples' lives, which drops mortality rates comparably to Pfizer and Moderna's.